Riskpilot← Back to searchSign inGet full accessPelvin AB
ABActiveOrg 5567305148Södra Strandgatan 5 BBusiness and other management consultancy activities · NACE 7020Est. 20071 employees
Revenue 2025
SEK 634K
0% vs 2024
EBITDA margin
45.4%
+113% vs 2024
Equity ratio
89.6%
Financial strength
Net profit 2025
SEK 229K
+102% vs 2024
| Revenue | SEK 634K | +0% |
| EBITDA | SEK 288K | +113% |
| Net profit | SEK 229K | +102% |
| Total assets | SEK 1,8M | +4% |
| Equity | SEK 1,6M | +2% |
| Employees | 1 | — |
Legal name
Pelvin AB
Org number
5567305148
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
24 maj 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Lewin, Ulf Peter
Company purpose
Bolaget ska bedriva konsultverksamhet och undervisning inom hälso och sjukvårdsområdet, inom informationsteknik och administration samt därmed förenlig verksamhet.
Address
Södra Strandgatan 5 B
Email
pelvinab@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 851 | 859 | 1 877 | 633 | 634 |
| Staff expenses | — | — | — | −362 | — |
| EBITDA | 461 | 505 | 788 | 135 | 288 |
| Depreciation & amort. | −3 | −3 | −3 | — | −0 |
| EBIT | 458 | 502 | 785 | 135 | 288 |
| Net financials | — | — | −8 | 6 | — |
| Profit before tax | 457 | 501 | 777 | 141 | 288 |
| Tax | −98 | −103 | −162 | −28 | −59 |
| Net profit | 359 | 398 | 615 | 113 | 229 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 485 | 1 722 | 2 410 | 1 739 | 1 810 |
| Equity | 1 129 | 1 343 | 1 770 | 1 594 | 1 622 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 356 | 379 | 640 | 145 | 188 |
| Total debt | 356 | 379 | 640 | 145 | 188 |
EBITDA margin
45.4%
This company
15.8%
Market median
+187% vs market
20212025
Equity ratio
89.6%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
14.1%
This company
18.4%
Market median
+23% vs market
20212025
Net profit margin
36.1%
This company
8.1%
Market median
+346% vs market
20212025
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pelvin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Per Gustaf Persson | Deputy Board Member | 0 companies |
| Ulf Peter Lewin | Chairman | 0 companies |
| Jasmina Popaja | Board of Directors | 0 companies |